N-carbamoyl nitrogen-containing fused ring compounds and drugs containing these compounds as the active ingredient
US7368444B2 · kind B2 · utility
12Cited by
8References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 13, 2003 |
| Grant date | May 6, 2008 |
| Priority date | — |
| Expiry date | Feb 13, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D223/16
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the compound presented by formula (I)(wherein all symbols in formula (I) are the same mean as the description shown in the specification.), mitocondorial benzogeazepin receptor (MBR) antagonist comprising the compound, the preventive and/or treatment medicine against diseases caused by stress of which an active ingredient is the compound.Since the compound represented by formula (I) has MBR antagonistic activity, and controls the production of neurosteroid, it is useful as the preventive and/or treatment medicine against diseases caused by stress.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.